查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1580963

基因型鉴定检测市场：按产品、技术、样本类型、应用和最终用户划分 - 2025-2030 年全球预测

Genotyping Assay Market by Offering (Instruments, Reagents & Kits, Software & Services), Technology (Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction), Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因型鉴定检测市值为179.3亿美元，预计到2024年将达到204.5亿美元，复合年增长率为14.42%，到2030年将达到460.6亿美元。

基因型鉴定测定是基因组学和生物技术中的重要工具，对于分析遗传变异至关重要，并且可以揭示疾病倾向、个人化医疗机会、农业创新等。对基因型鉴定测定的需求源于它们能够提供对遗传组成的详细了解并促进诊断应用、药物开发和精密农业。应用范围从帮助识别癌症和心血管疾病等疾病易感性的医疗保健，到提高作物復原力和产量的农业。製药、诊断、营养基因组学和动物育种等行业广泛将这些检测方法用于各种最终用途。

主要市场统计
基准年[2023] 179.3亿美元
预测年份 [2024] 204.5亿美元
预测年份 [2030] 460.6亿美元
复合年增长率（%） 14.42%

关键的成长要素包括精准医疗的进步、个人化医疗保健意识的增强以及农业生物技术的创新。基因型鉴定在药物开发平臺中的日益整合及其在根据个体遗传特征量身定制治疗方法的关键作用正在推动市场成长。由于次世代定序技术的增强以及与生物资讯学的整合以进行更全面的资料分析，基因型鉴定测定市场的扩大是一个新的商机，我们正在创新针对遗传资料的资料分析解决方案，这将为新兴企业开闢一条道路。

然而，与先进基因型鉴定技术相关的高成本、新兴市场缺乏意识以及对基因资料保密性的道德担忧对市场成长构成了挑战。此外，技术进步的快速发展需要持续的研发投资，这也可能导致敏感的监管障碍。

为了创新，公司可以专注于开发适合已开发市场和新兴市场的具有成本效益的便携式基因型鉴定平台。结合人工智慧和机器学习来简化遗传资料分析并提高预测和解释的效率和准确性的跨学科研究也具有巨大潜力。基因型鉴定检测市场的本质是高度动态的，受到快速技术进步的推动，积极主动地解决隐私问题，并强调利用技术协同效应效应的战略伙伴关係，从而提供巨大的成长机会。

市场动态：揭示快速发展的基因型鉴定检测市场的关键市场洞察

供需的动态交互作用正在改变基因型鉴定检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 个人化医疗需求不断成长
    • 遗传病患病率增加
    • 活性化基因型鉴定技术的研发
  • 市场限制因素
    • 维护和操作基因型鉴定设备和测试的成本高昂
  • 市场机会
    • 将基因型鉴定检测与数位健康平台和电子健康记录(EHR) 结合
    • 相关人员之间的持续合作
  • 市场挑战
    • 与基因型鉴定检测相关的复杂的监管合规性和伦理考虑

波特五力：驾驭基因型鉴定检测市场的策略工具

波特的五力架构是了解基因型鉴定检测市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因型鉴定检测市场的外部影响

外部宏观环境因素在塑造基因型鉴定检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因型鉴定检测市场的竞争格局

基因型鉴定检测市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵基因型鉴定检测市场供应商的绩效评估

FPNV定位矩阵是评估基因型鉴定检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了基因型鉴定检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因型鉴定检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 个人化医疗需求不断成长
      • 遗传性疾病增加
      • 增加基因分型技术的研发活动
    • 抑制因素
      • 维护和运行基因分型设备和测试的高成本
    • 机会
      • 将基因分型测试与数位健康平台和电子健康记录 (EHR) 结合
      • 相关人员之间的持续合作
    • 任务
      • 与基因型鉴定检测相关的复杂的监管合规性和伦理考虑
  • 市场区隔分析
    • 我们提供什么：增加研究实验室和医院设备的使用，以确保效率和准确性
    • 应用：透过扩大基因分型检测在农业的应用来提高农业产量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因型鉴定检测市场：透过提供

  • 装置
  • 试剂和套件
  • 软体和服务

第七章基因型鉴定检测市场：依技术分类

  • 微阵列分析
  • 次世代定序
  • 聚合酵素链锁反应
  • 桑格序列

第 8 章依样本类型基因型鉴定检测市场

  • 血液样本
  • 颊黏膜拭子
  • 唾液样本
  • 组织样本

第九章基因型鉴定检测市场：依应用分类

  • 农业
  • 动物遗传学
  • 诊断与个人化医疗
  • 药物基因组学

第 10 章基因型鉴定检测市场：依最终用户分类

  • 学术研究所
  • 合约调查机构
  • 医院/诊所
  • 製药和生物技术公司

第十一章美洲基因型鉴定检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区基因基因型鉴定检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲/中东/非洲基因型鉴定检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • BD 与 Healthians 合作提高家庭诊断的准确性并扩大印度的服务
    • Thermo Fisher Scientific 推出泛基因组阵列，彻底改变基因组研究与临床诊断
  • 战略分析和建议

公司名单

  • 3CR Bioscience Ltd.
  • Azenta Life Sciences
  • Bio-Rad Laboratories, Inc.
  • Chemagen Technologie GmbH
  • Danaher Corporation
  • Eurofins Scientific SE
  • Grifols, SA
  • Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Mayo Clinic Laboratories
  • NeoGenomics Laboratories, Inc.
  • New England Biolabs, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC.
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7B2F382F32

The Genotyping Assay Market was valued at USD 17.93 billion in 2023, expected to reach USD 20.45 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 46.06 billion by 2030.

Genotyping assays are critical tools in genomics and biotechnology, essential for analyzing genetic variations that can reveal predispositions to diseases, personalized medicine opportunities, and agricultural innovations. The necessity of genotyping assays stems from their ability to provide detailed insights into genetic compositions, facilitating diagnostic applications, drug development, and precision agriculture. Their applications span across healthcare, where they assist in identifying susceptibilities to diseases like cancer and cardiovascular disorders, and in agriculture, promoting crop resilience and yield. Industries such as pharmaceuticals, diagnostics, nutrigenomics, and animal breeding utilize these assays extensively for varied end-use purposes.

KEY MARKET STATISTICS
Base Year [2023] USD 17.93 billion
Estimated Year [2024] USD 20.45 billion
Forecast Year [2030] USD 46.06 billion
CAGR (%) 14.42%

Key growth influencers include advancements in precision medicine, rising awareness of personalized healthcare, and innovations in agricultural biotechnology. The increasing integration of genotyping in drug development pipelines and its critical role in tailoring therapies to individual genetic profiles propels market growth. Emerging opportunities lie in expanding the genotyping assays market through enhanced next-generation sequencing technologies and integration with bioinformatics for more comprehensive data analysis, creating pathways for startups to innovate in data analytics solutions tailored for genetic data.

However, market growth is challenged by high costs associated with advanced genotyping technologies, lack of awareness in emerging markets, and ethical concerns about genetic data confidentiality. Additionally, the fast-paced technological advancements necessitate continuous investment in R&D and may lead to regulatory hurdles that need careful navigation.

For innovation, businesses can focus on developing cost-effective and portable genotyping platforms suitable for both developed and emerging markets. There's also significant potential in interdisciplinary research, combining AI and machine learning to streamline genetic data analysis, improving the efficiency and accuracy of predictions and interpretations. The nature of the genotyping assay market is highly dynamic, driven by rapid technological advancements, and offers vast opportunities for growth with a proactive stance on addressing privacy concerns and an emphasis on strategic partnerships that leverage technological synergies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Assay Market

The Genotyping Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for personalized medicine
    • Increasing prevalence of genetic disorders
    • Increased research and development activities in genotyping technologies
  • Market Restraints
    • High costs associated with maintaining, and running genotyping equipment and tests
  • Market Opportunities
    • Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
    • Ongoing collaborative activities between stakeholders
  • Market Challenges
    • Complex regulatory compliances and ethical considerations associated with genotyping assay

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Assay Market

A detailed market share analysis in the Genotyping Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Assay Market

A strategic analysis of the Genotyping Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Assay Market, highlighting leading vendors and their innovative profiles. These include 3CR Bioscience Ltd., Azenta Life Sciences, Bio-Rad Laboratories, Inc., Chemagen Technologie GmbH, Danaher Corporation, Eurofins Scientific SE, Grifols, S.A., Hoffmann-La Roche Ltd., Illumina, Inc., LGC Biosearch Technologies, Mayo Clinic Laboratories, NeoGenomics Laboratories, Inc., New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Promega Corporation, QIAGEN GmbH, Standard BioTools Inc., TAKARA BIO INC., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Kits, and Software & Services.
  • Based on Technology, market is studied across Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction, and Sanger Sequencing.
  • Based on Sample Type, market is studied across Blood Sample, Buccal Swab, Saliva Sample, and Tissue Sample.
  • Based on Application, market is studied across Agriculture, Animal Genetics, Diagnostics & Personalized Medicine, and Pharmacogenomics.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicine
      • 5.1.1.2. Increasing prevalence of genetic disorders
      • 5.1.1.3. Increased research and development activities in genotyping technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with maintaining, and running genotyping equipment and tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
      • 5.1.3.2. Ongoing collaborative activities between stakeholders
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory compliances and ethical considerations associated with genotyping assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Growing usage of instruments in research labs and hospitals for ensuring efficiency and precision
    • 5.2.2. Application: Increasing usage of genotyping assays in agriculture for enhancing agricultural yields
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genotyping Assay Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Software & Services

7. Genotyping Assay Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray Analysis
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction
  • 7.5. Sanger Sequencing

8. Genotyping Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Sample
  • 8.3. Buccal Swab
  • 8.4. Saliva Sample
  • 8.5. Tissue Sample

9. Genotyping Assay Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture
  • 9.3. Animal Genetics
  • 9.4. Diagnostics & Personalized Medicine
  • 9.5. Pharmacogenomics

10. Genotyping Assay Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotech Companies

11. Americas Genotyping Assay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genotyping Assay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genotyping Assay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. BD Partners with Healthians to Boost Home Diagnostic Accuracy and Expand Services in India
    • 14.3.2. Thermo Fisher Scientific Launches Pangenomix Array to Revolutionize Genomic Research and Clinical Diagnostics
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3CR Bioscience Ltd.
  • 2. Azenta Life Sciences
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Chemagen Technologie GmbH
  • 5. Danaher Corporation
  • 6. Eurofins Scientific SE
  • 7. Grifols, S.A.
  • 8. Hoffmann-La Roche Ltd.
  • 9. Illumina, Inc.
  • 10. LGC Biosearch Technologies
  • 11. Mayo Clinic Laboratories
  • 12. NeoGenomics Laboratories, Inc.
  • 13. New England Biolabs, Inc.
  • 14. Novogene Co., Ltd.
  • 15. Oxford Nanopore Technologies PLC.
  • 16. Pacific Biosciences of California, Inc.
  • 17. Paragon Genomics, Inc.
  • 18. Promega Corporation
  • 19. QIAGEN GmbH
  • 20. Standard BioTools Inc.
  • 21. TAKARA BIO INC.
  • 22. Tecan Trading AG
  • 23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENOTYPING ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. GENOTYPING ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOTYPING ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOTYPING ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SALIVA SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TISSUE SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023